398 results on '"Nakashima, Taku"'
Search Results
52. Primary Pulmonary Mucosa-associated Lymphoid Tissue Lymphoma with the High Expression of IgG4: A Case Report
53. Dupilumab as an adjunct treatment for a patient with steroid-dependent immunoglobulin G4-related disease complicated by asthma: a case report
54. Dupilumab as an adjunct treatment for a patient with steroid-dependent immunoglobulin G4-related disease complicated by asthma: a case report.
55. Primary pulmonary extranodal NK/T-cell lymphoma diagnosed by thoracoscopic lung biopsy: A case report
56. Pneumatosis Intestinalis following Radiation Esophagitis during Chemoradiotherapy for Lung Cancer: A Case Report
57. Tolerability and efficacy of IMpower133 regimen modified for dialysis patients with extensive‐stage small cell lung cancer: Two case reports
58. Accelerated decline in lung function in adults with a history of remitted childhood asthma
59. MT95-4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse model
60. MO10-2 Association of pre-existing interstitial lung abnormalities with immune checkpoint inhibitor-induced interstitial lung disease among patients with non-lung cancers
61. IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis
62. Prognostic Significance of EGFR Gene Mutation in Patients With EGFR Mutated Non-small Cell Lung Cancer Who Received Best Supportive Care Alone
63. Additional file 3 of Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
64. Additional file 5 of Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
65. Additional file 9 of Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
66. Additional file 7 of Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
67. Additional file 1 of Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
68. Additional file 4 of Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
69. Additional file 2 of Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
70. Additional file 1 of Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
71. Additional file 6 of Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
72. Additional file 4 of Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
73. Additional file 8 of Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
74. Additional file 3 of Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
75. Additional file 8 of Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
76. Additional file 6 of Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
77. Additional file 2 of Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
78. Additional file 1 of Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis
79. Additional file 7 of Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
80. Vocal cord dysfunction detected by a three-dimensional image of dynamic change in respiratory resistance in a patient with difficult-to-treat asthma: a case report.
81. Prediction of radiation pneumonitis after definitive radiotherapy for locally advanced non-small cell lung cancer using multi-region radiomics analysis
82. Vocal cord dysfunction detected by a three-dimensional image of dynamic change in respiratory resistance in a patient with difficult-to-treat asthma: a case report
83. Risk factors associated with increased discontinuation rate of trimethoprim–sulfamethoxazole used as a primary prophylaxis for Pneumocystis pneumonia: A retrospective cohort study
84. Analysis of microRNA Expression in Liquid-Based Cytology Samples May Be Useful for Primary Lung Cancer Diagnosis
85. Autoantibody Positivity Is a Risk Factor for Chemotherapy-induced Exacerbation of Interstitial Pneumonia in Lung Cancer
86. D-dimer can be a diagnostic marker for cisplatin-related aortic thrombosis
87. A machine-learning based approach to quantify fine crackles in the diagnosis of interstitial pneumonia
88. Alectinib-induced Immune Hemolytic Anemia in a Patient with Lung Adenocarcinoma
89. Increased of Receptor Type Tyrosine Kinase Ros1 in Interstitial Lung Disease: PS417
90. Bronchoalveolar Lavage Cellular Pattern Can Predict the Prognosis of Patients with Chronic Hypersensitivity Pneumonitis: OS249
91. Comparison of KL-6, SP-A, SP-D, 8-Isoprostane, MMP-9, and TIMP-1 as Serum Biomarkers for Patients with Combined Pulmonary Fibrosis and Emphysema: OS180
92. Additional file 1 of Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis
93. Two Cases of Cranial Nerve Metastasis Treated with Radiotherapy and Chemotherapy in Patients with Lung Adenocarcinoma
94. Association of Preexisting Interstitial Lung Abnormalities With Immune Checkpoint Inhibitor–Induced Interstitial Lung Disease Among Patients With Nonlung Cancers
95. Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non‐small cell lung cancer
96. Concomitant emphysema might increase the false-negative rate of urinary antigen tests in patients with pneumococcal pneumonia: results from a retrospective study
97. Lung Bone Marrow-derived Hematopoietic Progenitor Cells Enhance Pulmonary Fibrosis
98. Essential role of stem cell factor–c-Kit signalling pathway in bleomycin-induced pulmonary fibrosis
99. Recruitment of bone marrow derived CD11c+ and c-Kit+ cells in pulmonary fibrosis: CS15-5
100. Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.